Targeted identification of risk and treatment of diabetic kidney disease

Competing interests

S.J.G. has received honoraria for presentations and advisory board roles from Astra Zeneca, Bayer, Boehringer Ingelheim, Eli Lilly and Novo Nordisk. C.A.P. has received honoraria for presentations and advisory board roles from Astra Zeneca, Bayer, Eli Lilly, Boehringer Ingelheim and Otsuka.

Comments (0)

No login
gif